3Smith JS, Lindsay L, Hoots B, et al. Human papilloma virus type distridution in vasive cervical cancer and high- grade cervical lesions [ J ]. Int J Cancer, 2007,121 (6) : 621-632.
4Duensing S, Mungen K. Mechanisms of genomic instability in human cancer : insights from study with human papiloma virus oncoproteins [ J ]. Int J Cancer,2004,109 (9) : 157-162.
5Brabin L, Roberts SA, Farzanch F, et al. Future acceptance of adolescent human papilloma virus vaccination [ J ]. Vaccine, 2006,24 ( 9 ) : 3087-3094.
二级参考文献7
1zur Hausen H. Papilloma virus and cancer: from basic studies to clinical application. Nat Rev Cancer, 2002, 2:342-350.
2Cuzick J, Clavel C, Petry KU, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 2006,119 : 1095-1101.
3Lo KW, Wong YF, Chan MK, et al. Prevalence of human papillomavirus in cervical cancer: a multicenter study in China. Int J Cancer,2002,100:327-331.
5Bisscotti CV,Dawson AE,Dziura B,et al.Assisted primaryscreening using the automated thin prep imaging system[J].AmJ Clin Pathol,2005,123:281-287.
6Lukaszuk K,Liss J,Wozniak I,et al.Human papil-loma virustype 16 sta-tus in cervical carcinoma cell DNA assayed by multiplex PCR[J].JC lingMicrobiol,2003,41 (2):608-612.
7Josephine A,Catherine HK,Cecine T B,et al.Cenmic polymorphism ofhuman papillomavirus type 52 predisposes toward persistent infection insexually active women[JJ.Infec Dis,2004,90 (1):46-52.
8Bosch FX,ManosMM,MunozN,et al.Prevalence ofhuman papi-lloma virus in cervical cancer:aworldwide perspective.Internationabiological study on cervical cancer (1BSCC) Study Group[J].JNatiCancer Inst,1995,87:796-802.
9VizcainoAP,MorenoV,Bosch FX,et al.International trends inincidence of cervical cancer:Ⅱ.Squamous-cell carcinoma[J].Int JCancer,2000,86:429-435.
10Kawana K, Yasug/T, Taketani Y. Human papi|lomavirus vaccines: current issues and future[J]. Indian J Med Res, 2009, 130(3) : 341 - 347.
